603520 Zhejiang Starry Pharmaceutical Co., Ltd. SSE · China

Zhejiang Starry Pharmaceutical Co. (603520) news

Zhejiang Starry Pharmaceutical Co., Ltd. is a public biotech or pharmaceutical company listed on SSE under the ticker 603520, recorded under China. The directory classifies it as Pharmaceuticals / APIs. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Zhejiang Starry Pharmaceutical Co. news

We have not published a story on Zhejiang Starry Pharmaceutical Co. yet. When there is news, it will appear here.

Questions about Zhejiang Starry Pharmaceutical Co.

What is the ticker symbol of Zhejiang Starry Pharmaceutical Co.?

Zhejiang Starry Pharmaceutical Co., Ltd. trades under the ticker 603520 on SSE.

Where is Zhejiang Starry Pharmaceutical Co. listed?

Zhejiang Starry Pharmaceutical Co., Ltd. is listed on SSE.

Which country or territory is Zhejiang Starry Pharmaceutical Co. listed under?

Our directory records Zhejiang Starry Pharmaceutical Co., Ltd. under China.

What does Zhejiang Starry Pharmaceutical Co. do?

Our directory classifies Zhejiang Starry Pharmaceutical Co., Ltd. as: Pharmaceuticals / APIs. This is a directory classification, not a description of the pipeline.

What is the ISIN of Zhejiang Starry Pharmaceutical Co.?

The ISIN recorded for Zhejiang Starry Pharmaceutical Co., Ltd. is CNE1000026N8.

Does aibio.space cover Zhejiang Starry Pharmaceutical Co.?

aibio.space lists Zhejiang Starry Pharmaceutical Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Zhejiang Starry Pharmaceutical Co.?

Companies in our directory listed in the same country and business area as Zhejiang Starry Pharmaceutical Co.: Shandong Keyuan Pharmaceutical Co., Hubei Hongyuan Pharmaceutical Technology Co., Zhejiang Haisen Pharmaceutical Co., Suzhou Fushilai Pharmaceutical Co., JW (Cayman) Therapeutics Co., Shandong Boan Biotechnology Company., Limited..

Investor discussion: Zhejiang Starry Pharmaceutical Co.

Members talk about Zhejiang Starry Pharmaceutical Co. (603520). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:603520 on TradingView.

Listing details

Company: Zhejiang Starry Pharmaceutical Co., Ltd.
Ticker: 603520
Listing: SSE
Country or territory: China
Business scope: Pharmaceuticals / APIs
ISIN: CNE1000026N8
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction